Breast cancer treatment is not recommended.

Breast cancer is a common clinical malignancy. Most patients show HER-2 positive immunohistochemistry, and targeted therapy is an option, which is a way to treat the diagnosed lesion at the cellular level. However, if HER-2 is positive immunohistochemistry, targeted therapy should not be performed.